|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.640 USD | -0.58% |
|
+1.17% | +28.57% |
| 04-09 | Sanofi Now Holds Marketing Authorization for COVID-19 Vaccine Nuvaxovid in Canada | MT |
| 04-09 | B. Riley Raises Price Target on Novavax to $18 from $16, Keeps Buy Rating | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.58% | +1.17% | -14.29% | +7.87% | +28.57% | +39.35% | -5.68% | -96.20% | -92.10% | 1.41B | |
| +0.53% | +4.00% | +9.69% | -1.90% | -0.41% | -0.67% | -9.25% | -3.74% | +224.61% | 47.35B | |
| +0.24% | +2.32% | +10.72% | -5.17% | +5.56% | +40.57% | +21.48% | +4.96% | +904.70% | 35.57B | |
| -2.14% | +55.13% | +50.78% | +24.10% | +87.41% | +312.35% | +574.21% | +270.21% | - | 31.16B | |
| -3.45% | +1.76% | +4.28% | -27.65% | -23.72% | +15.84% | -14.18% | -20.23% | +145.33% | 28.86B | |
| +3.47% | +3.72% | +4.50% | 0.00% | +15.47% | +36.62% | +29.82% | -21.39% | +161.79% | 29.62B | |
| +0.51% | +0.51% | +5.16% | +18.03% | +13.93% | +53.62% | +199.31% | +99.22% | +1,285.12% | 15.01B | |
| -0.56% | +2.82% | +13.67% | -15.59% | -8.19% | +73.91% | +168.37% | +186.63% | - | 14.73B | |
| +2.55% | +8.52% | +34.79% | +11.45% | +45.57% | +4,163.00% | +4,049.02% | - | - | 15.12B | |
| +0.84% | +8.82% | +12.21% | -2.92% | +11.89% | +40.85% | +13.53% | -21.10% | +114.80% | 14.34B | |
| -2.03% | -1.53% | +4.04% | -1.40% | -4.87% | +165.47% | +103.41% | +84.55% | +77.17% | 12.43B | |
| -3.53% | +23.23% | +6.96% | -22.62% | -7.84% | +33.19% | - | - | - | 9.75B | |
| +2.23% | -2.22% | -3.74% | +4.46% | -12.38% | +1,913.36% | +900.95% | +413.38% | +932.29% | 9.62B | |
| -5.75% | +0.05% | +5.05% | +0.99% | +8.70% | +974.23% | +2,035.93% | -21.96% | - | 8.92B | |
| -1.93% | +3.22% | +17.52% | -16.47% | -2.47% | +14.78% | -32.71% | -45.18% | +146.90% | 8.97B | |
| -2.00% | +0.79% | +16.43% | -19.46% | -11.30% | +69.73% | -13.13% | -45.28% | +119.88% | 8.73B | |
| -0.79% | +8.32% | +18.41% | -36.71% | -36.57% | -19.48% | -44.90% | -43.47% | +57.79% | 8.83B | |
| -1.63% | -0.12% | +0.10% | -13.90% | -13.47% | -6.10% | -21.12% | -30.43% | +52.31% | 8.47B | |
| +0.29% | +2.75% | +12.63% | -1.72% | +10.41% | +41.33% | -15.16% | -51.79% | - | 7.78B | |
| -3.21% | -1.39% | +8.22% | +23.87% | +10.71% | +244.28% | +162.14% | +122.81% | - | 7.03B | |
| Average | -0.45% | +6.19% | +10.86% | -3.74% | +5.85% | +410.31% | +426.42% | +43.39% | +317.74% | 16.19B | |
| Weighted average by Cap. | -0.08% | +8.86% | +13.55% | -2.87% | +9.53% | +340.41% | +362.20% | +49.70% | +374.55% |
- Stock Market
- Equities
- NVAX Stock
- Sector Novavax, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition